High-cost drugs, high-risk claims
A single infusion claim can be worth thousands. A missing authorization, dose detail or wasted-drug record means a costly denial.
Oncology claims are among the largest a practice sends, and the most closely reviewed. XEHR connects treatment plans, administration records, authorizations and claims.
Cycle 3 visit; tolerating treatment well.
C50.911 Breast cancer, right
A single infusion claim can be worth thousands. A missing authorization, dose detail or wasted-drug record means a costly denial.
Regimens and their supporting drugs need approval, often with pathology and staging attached.
Patients need to know what they will owe before treatment starts.
Medical oncology is built around treatment cycles. Office visits, chemotherapy and immunotherapy infusions, supportive drugs and lab work all happen in the practice, and each infusion day can carry several drugs and hours of administration on one claim. Drug costs dominate revenue, which makes prior authorization, correct units and timely filing the difference between a sustainable practice and a losing one.
| C50.911 | Malignant neoplasm of unspecified site of right female breast |
| C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
| C18.9 | Malignant neoplasm of colon, unspecified |
| C61 | Malignant neoplasm of prostate |
| Z51.11 | Encounter for antineoplastic chemotherapy |
| D70.1 | Agranulocytosis secondary to cancer chemotherapy |
Examples only. The provider chooses the code that matches the documented diagnosis, and XEHR checks it against the note and the payer's rules before the claim goes out.
The treatment plan is documented with the diagnosis and stage, and every drug that needs prior authorization is flagged before the first cycle.
Counts and chemistries are in the chart before treatment, so the hold-or-treat decision is documented in one place.
Each drug, dose, unit, start and stop time is recorded during the infusion, along with any reaction.
Drugs, administration and the visit go on one checked claim; the next cycle and its approvals are already in view.
| Service | Dx | Units | Charge |
|---|---|---|---|
| Office visit | E11.9 | 1 | 145.00 |
| A1c test | E11.9 | 1 | 28.00 |
| Total | 173.00 | ||
XEHR is an agentic EHR: AI agents do the administrative work around every oncology visit, and your team approves what matters. How agentic AI works
Ask every vendor, including us. The answers show whether a system was built for oncology work or only adapted to it.
Ask us on a demoYes. Administration details from the note carry onto the claim, and the claim is checked before it goes out.
Yes. Requests are prepared from the chart and tracked, and your staff reviews and submits them.
Yes. Drugs, units and administration times are captured in the infusion record and carried to the claim.
Yes. Approvals are tracked against the regimen, so a cycle is not given on an expired authorization.
Yes. Research and routine services can be separated on the claim as payers require.
Yes. Each approval is tracked with its end date on the patient’s record.
Pricing is published: $189 per provider per month for the Clinical plan, $449 per provider per month for the Practice Suite with billing, or 2.5% of collections for RCM as a Service. Month-to-month, with a BAA on every plan. See pricing.
Small practices are usually live in 2 to 4 weeks, including setup, data migration and training. We agree the plan with you before you sign.
A 30-minute walkthrough on a live test environment, with your specialty's templates and billing.
Powered by XEHR